| Primary |
| Skin Wrinkling |
28.8% |
| Muscle Spasticity |
17.6% |
| Drug Use For Unknown Indication |
13.6% |
| Off Label Use |
8.1% |
| Skin Cosmetic Procedure |
7.9% |
| Product Used For Unknown Indication |
7.8% |
| Torticollis |
3.4% |
| Neurogenic Bladder |
2.3% |
| Blepharospasm |
1.9% |
| Dystonia |
1.1% |
| Eyelid Ptosis |
1.1% |
| Hyperhidrosis |
0.9% |
| Migraine |
0.9% |
| Salivary Hypersecretion |
0.9% |
| Hypertonic Bladder |
0.7% |
| Muscle Spasms |
0.7% |
| Therapeutic Procedure |
0.7% |
| Headache |
0.5% |
| Hemiparesis |
0.5% |
| Myofascial Pain Syndrome |
0.5% |
|
| Muscular Weakness |
14.8% |
| Wrong Technique In Drug Usage Process |
12.3% |
| Vision Blurred |
7.2% |
| Eyelid Ptosis |
5.9% |
| Dysphagia |
5.5% |
| Off Label Use |
5.5% |
| Weight Decreased |
5.5% |
| Pain In Extremity |
3.8% |
| Speech Disorder |
3.8% |
| Swelling Face |
3.8% |
| Fatigue |
3.4% |
| Neck Pain |
3.4% |
| Product Quality Issue |
3.4% |
| Viith Nerve Paralysis |
3.4% |
| Vomiting |
3.4% |
| Drug Ineffective |
3.0% |
| Malaise |
3.0% |
| Respiratory Disorder |
3.0% |
| Unevaluable Event |
3.0% |
| Visual Impairment |
3.0% |
|
| Secondary |
| Skin Wrinkling |
29.6% |
| Product Used For Unknown Indication |
23.9% |
| Off Label Use |
9.0% |
| Skin Cosmetic Procedure |
8.2% |
| Drug Use For Unknown Indication |
6.2% |
| Muscle Spasticity |
4.1% |
| Eyelid Ptosis |
3.6% |
| Blepharospasm |
3.1% |
| Ulcerative Keratitis |
2.3% |
| Mental Disorder |
2.1% |
| Conjunctivitis |
1.5% |
| Pemphigoid |
1.5% |
| Restless Legs Syndrome |
1.0% |
| Hypertonic Bladder |
0.8% |
| Muscle Spasms |
0.8% |
| Facial Spasm |
0.5% |
| Neurogenic Bladder |
0.5% |
| Scleritis |
0.5% |
| Torticollis |
0.5% |
| Amyotrophic Lateral Sclerosis |
0.3% |
|
| Wrong Technique In Drug Usage Process |
22.8% |
| Keratitis |
12.7% |
| Drug Ineffective |
6.3% |
| Muscular Weakness |
6.3% |
| Speech Disorder |
5.1% |
| Toothache |
5.1% |
| Vitreous Detachment |
5.1% |
| Asthenia |
3.8% |
| Headache |
3.8% |
| Vision Blurred |
3.8% |
| Dysphagia |
2.5% |
| Eyelid Ptosis |
2.5% |
| Muscle Twitching |
2.5% |
| Musculoskeletal Stiffness |
2.5% |
| Skin Tightness |
2.5% |
| Swelling Face |
2.5% |
| Throat Tightness |
2.5% |
| Treatment Failure |
2.5% |
| Viith Nerve Paralysis |
2.5% |
| Vomiting |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.5% |
| Torticollis |
18.8% |
| Head Titubation |
10.3% |
| Skin Wrinkling |
9.4% |
| Supplementation Therapy |
6.8% |
| Colitis |
2.6% |
| Crohn's Disease |
2.6% |
| Feeling Of Relaxation |
2.6% |
| Fibromyalgia |
2.6% |
| Hot Flush |
2.6% |
| Insomnia |
2.6% |
| Muscle Relaxant Therapy |
2.6% |
| Muscle Tightness |
2.6% |
| Urinary Incontinence |
2.6% |
| Urinary Tract Disorder |
2.6% |
| Analgesic Therapy |
1.7% |
| Blepharospasm |
1.7% |
| Contraception |
1.7% |
| Decreased Appetite |
1.7% |
| Diuretic Therapy |
1.7% |
|
| Tachycardia |
19.0% |
| Ocular Hyperaemia |
9.5% |
| Urinary Tract Infection |
9.5% |
| Ventricular Extrasystoles |
9.5% |
| Dysphagia |
4.8% |
| Hypertension |
4.8% |
| Hypoaesthesia |
4.8% |
| Injection Site Pain |
4.8% |
| Injection Site Pruritus |
4.8% |
| Skin Tightness |
4.8% |
| Strabismus |
4.8% |
| Subcutaneous Nodule |
4.8% |
| Throat Tightness |
4.8% |
| Tremor |
4.8% |
| Vomiting |
4.8% |
|
| Interacting |
|
| Dyspnoea |
33.3% |
| Muscular Weakness |
33.3% |
| Potentiating Drug Interaction |
33.3% |
|
